Table 3 Heterozygous inactivation of EPCAM and/or MSH2 in colorectal and endometrial cancer risk of carriers of different germline mutations inactivating MSH2 , elaborated by Ligtenberg et al. (2012)

From: Germline deletions in the EPCAM gene as a cause of Lynch syndrome – literature review